Primary CNS Lymphoma
Conditions
Interventions
Trial group:Lenalidomide
Sponsors
Huashan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
65 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) The age is 65-80 years old, both male and female; 2) Non Hodgkin's lymphoma was diagnosed by histopathology and immunohistochemical staining, and no systemic LYMPHOPOIETIC tissue or other system involvement was found after strict physical examination and auxiliary examination; 3) PET-CT showed complete remission after chemotherapy; 4) The subjects read and fully understood the patient's instructions and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Combined with other malignant tumors; 2) Severe heart failure, liver dysfunction or renal insufficiency; 3) Severe arrhythmia; 4) Pregnancy or lactation of women; 5) Recent participants in other clinical trials; 6) Other major diseases or mental disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS;relapse rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| ORR;OS;Incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactYan Ma
Huashan Hospital, Fudan University
Outcome results
None listed